Kelly KA - Search Results

1

Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle.

Kelly KA, Allport JR, Tsourkas A, Shinde-Patil VR, Josephson L, Weissleder R. Kelly KA, et al. Circ Res. 2005 Feb 18;96(3):327-36. doi: 10.1161/01.RES.0000155722.17881.dd. Epub 2005 Jan 13. Circ Res. 2005. PMID: 15653572

2

Detection of invasive colon cancer using a novel, targeted, library-derived fluorescent peptide.

Kelly K, Alencar H, Funovics M, Mahmood U, Weissleder R. Kelly K, et al. Cancer Res. 2004 Sep 1;64(17):6247-51. doi: 10.1158/0008-5472.CAN-04-0817. Cancer Res. 2004. PMID: 15342411

3

In vivo imaging of activated endothelium using an anti-VCAM-1 magnetooptical probe.

Tsourkas A, Shinde-Patil VR, Kelly KA, Patel P, Wolley A, Allport JR, Weissleder R. Tsourkas A, et al. Among authors: kelly ka. Bioconjug Chem. 2005 May-Jun;16(3):576-81. doi: 10.1021/bc050002e. Bioconjug Chem. 2005. PMID: 15898724

4

Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis.

Nahrendorf M, Jaffer FA, Kelly KA, Sosnovik DE, Aikawa E, Libby P, Weissleder R. Nahrendorf M, et al. Among authors: kelly ka. Circulation. 2006 Oct 3;114(14):1504-11. doi: 10.1161/CIRCULATIONAHA.106.646380. Epub 2006 Sep 25. Circulation. 2006. PMID: 17000904

5

Cell-specific targeting of nanoparticles by multivalent attachment of small molecules.

Weissleder R, Kelly K, Sun EY, Shtatland T, Josephson L. Weissleder R, et al. Nat Biotechnol. 2005 Nov;23(11):1418-23. doi: 10.1038/nbt1159. Epub 2005 Oct 23. Nat Biotechnol. 2005. PMID: 16244656

6

Fluorescein isothiocyanate-hapten immunoassay for determination of peptide-cell interactions.

Kelly KA, Reynolds F, Weissleder R, Josephson L. Kelly KA, et al. Anal Biochem. 2004 Jul 15;330(2):181-5. doi: 10.1016/j.ab.2004.02.035. Anal Biochem. 2004. PMID: 15203322

7

High-throughput identification of phage-derived imaging agents.

Kelly KA, Clemons PA, Yu AM, Weissleder R. Kelly KA, et al. Mol Imaging. 2006 Jan-Mar;5(1):24-30. Mol Imaging. 2006. PMID: 16779967

8

In vivo phage display selection yields atherosclerotic plaque targeted peptides for imaging.

Kelly KA, Nahrendorf M, Yu AM, Reynolds F, Weissleder R. Kelly KA, et al. Mol Imaging Biol. 2006 Jul-Aug;8(4):201-7. doi: 10.1007/s11307-006-0043-6. Mol Imaging Biol. 2006. PMID: 16791746

9

Cellular imaging of inflammation in atherosclerosis using magnetofluorescent nanomaterials.

Jaffer FA, Nahrendorf M, Sosnovik D, Kelly KA, Aikawa E, Weissleder R. Jaffer FA, et al. Among authors: kelly ka. Mol Imaging. 2006 Apr-Jun;5(2):85-92. Mol Imaging. 2006. PMID: 16954022

10

SPARC is a VCAM-1 counter-ligand that mediates leukocyte transmigration.

Kelly KA, Allport JR, Yu AM, Sinh S, Sage EH, Gerszten RE, Weissleder R. Kelly KA, et al. J Leukoc Biol. 2007 Mar;81(3):748-56. doi: 10.1189/jlb.1105664. Epub 2006 Dec 18. J Leukoc Biol. 2007. PMID: 17178915

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

572 results

Search Page

Filters